FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897822636> ?p ?o ?g. }

• W2897822636 endingPage "1264" @default.
• W2897822636 startingPage "1255" @default.
• W2897822636 abstract "Cytomegalovirus (CMV) infections that are refractory or resistant (RR) to available antivirals ([val]ganciclovir, foscarnet, cidofovir) are associated with higher mortality in transplant patients. Maribavir is active against RR CMV strains.Hematopoietic-cell or solid-organ transplant recipients ≥12 years old with RR CMV infections and plasma CMV deoxyribonucleic acid (DNA) ≥1000 copies/mL were randomized (1:1:1) to twice-daily dose-blinded maribavir 400, 800, or 1200 mg for up to 24 weeks. The primary efficacy endpoint was the proportion of patients with confirmed undetectable plasma CMV DNA within 6 weeks of treatment. Safety analyses included the frequency and severity of treatment-emergent adverse events (TEAEs).From July 2012 to December 2014, 120 patients were randomized and treated (40 per dose group): 80/120 (67%) patients achieved undetectable CMV DNA within 6 weeks of treatment (95% confidence interval, 57-75%), with rates of 70%, 63%, and 68%, respectively, for maribavir 400, 800, and 1200 mg twice daily. Recurrent on-treatment CMV infections occurred in 25 patients; 13 developed mutations conferring maribavir resistance. Maribavir was discontinued due to adverse events in 41/120 (34%) patients, and 17/41 discontinued due to CMV infections. During the study, 32 (27%) patients died, 4 due to CMV disease. Dysgeusia was the most common TEAE (78/120; 65%) and led to maribavir discontinuation in 1 patient. Absolute neutrophil counts <1000/µL were noted in 12/106 (11%) evaluable patients, with rates similar across doses.Maribavir ≥400 mg twice daily was active against RR CMV infections in transplant recipients; no new safety signals were identified.NCT01611974." @default.
• W2897822636 created "2018-10-26" @default.
• W2897822636 creator A5005410152 @default.
• W2897822636 creator A5011325960 @default.
• W2897822636 creator A5038572943 @default.
• W2897822636 creator A5047833636 @default.
• W2897822636 creator A5048614615 @default.
• W2897822636 creator A5052203408 @default.
• W2897822636 creator A5059942127 @default.
• W2897822636 creator A5061536627 @default.
• W2897822636 creator A5067628089 @default.
• W2897822636 creator A5079087824 @default.
• W2897822636 creator A5088776058 @default.
• W2897822636 date "2018-10-16" @default.
• W2897822636 modified "2023-10-17" @default.
• W2897822636 title "Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study" @default.
• W2897822636 cites W1478343394 @default.
• W2897822636 cites W1533537097 @default.
• W2897822636 cites W1953871740 @default.
• W2897822636 cites W1989700483 @default.
• W2897822636 cites W1993163623 @default.
• W2897822636 cites W1996558200 @default.
• W2897822636 cites W2008397578 @default.
• W2897822636 cites W2009864005 @default.
• W2897822636 cites W2024742119 @default.
• W2897822636 cites W2036707789 @default.
• W2897822636 cites W2040541452 @default.
• W2897822636 cites W2051304314 @default.
• W2897822636 cites W2054364001 @default.
• W2897822636 cites W2085476296 @default.
• W2897822636 cites W2096682430 @default.
• W2897822636 cites W2105193766 @default.
• W2897822636 cites W2106227497 @default.
• W2897822636 cites W2108031455 @default.
• W2897822636 cites W2109230548 @default.
• W2897822636 cites W2117471032 @default.
• W2897822636 cites W2129282759 @default.
• W2897822636 cites W2129477930 @default.
• W2897822636 cites W2129747821 @default.
• W2897822636 cites W2138063282 @default.
• W2897822636 cites W2148832620 @default.
• W2897822636 cites W2153568126 @default.
• W2897822636 cites W2155477672 @default.
• W2897822636 cites W2161600613 @default.
• W2897822636 cites W2168046861 @default.
• W2897822636 cites W2172252463 @default.
• W2897822636 cites W2501406433 @default.
• W2897822636 cites W2557770881 @default.
• W2897822636 cites W2601354919 @default.
• W2897822636 cites W2771598353 @default.
• W2897822636 doi "https://doi.org/10.1093/cid/ciy706" @default.
• W2897822636 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6451997" @default.
• W2897822636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30329038" @default.
• W2897822636 hasPublicationYear "2018" @default.
• W2897822636 type Work @default.
• W2897822636 sameAs 2897822636 @default.
• W2897822636 citedByCount "120" @default.
• W2897822636 countsByYear W28978226362018 @default.
• W2897822636 countsByYear W28978226362019 @default.
• W2897822636 countsByYear W28978226362020 @default.
• W2897822636 countsByYear W28978226362021 @default.
• W2897822636 countsByYear W28978226362022 @default.
• W2897822636 countsByYear W28978226362023 @default.
• W2897822636 crossrefType "journal-article" @default.
• W2897822636 hasAuthorship W2897822636A5005410152 @default.
• W2897822636 hasAuthorship W2897822636A5011325960 @default.
• W2897822636 hasAuthorship W2897822636A5038572943 @default.
• W2897822636 hasAuthorship W2897822636A5047833636 @default.
• W2897822636 hasAuthorship W2897822636A5048614615 @default.
• W2897822636 hasAuthorship W2897822636A5052203408 @default.
• W2897822636 hasAuthorship W2897822636A5059942127 @default.
• W2897822636 hasAuthorship W2897822636A5061536627 @default.
• W2897822636 hasAuthorship W2897822636A5067628089 @default.
• W2897822636 hasAuthorship W2897822636A5079087824 @default.
• W2897822636 hasAuthorship W2897822636A5088776058 @default.
• W2897822636 hasBestOaLocation W28978226361 @default.
• W2897822636 hasConcept C126322002 @default.
• W2897822636 hasConcept C168563851 @default.
• W2897822636 hasConcept C197934379 @default.
• W2897822636 hasConcept C203014093 @default.
• W2897822636 hasConcept C203092338 @default.
• W2897822636 hasConcept C2522874641 @default.
• W2897822636 hasConcept C2776724271 @default.
• W2897822636 hasConcept C2777054765 @default.
• W2897822636 hasConcept C2777965375 @default.
• W2897822636 hasConcept C2778715236 @default.
• W2897822636 hasConcept C2779820661 @default.
• W2897822636 hasConcept C2911091166 @default.
• W2897822636 hasConcept C71924100 @default.
• W2897822636 hasConcept C90924648 @default.
• W2897822636 hasConceptScore W2897822636C126322002 @default.
• W2897822636 hasConceptScore W2897822636C168563851 @default.
• W2897822636 hasConceptScore W2897822636C197934379 @default.
• W2897822636 hasConceptScore W2897822636C203014093 @default.
• W2897822636 hasConceptScore W2897822636C203092338 @default.
• W2897822636 hasConceptScore W2897822636C2522874641 @default.
• W2897822636 hasConceptScore W2897822636C2776724271 @default.
• W2897822636 hasConceptScore W2897822636C2777054765 @default.

• next